IL-17F Genetic Variants and Rheumatoid Arthritis: Impact on Protein Stability

What is it about?

This study investigates the association between three genetic variants (rs2397084, rs11465553, and rs763780) of the interleukin-17F (IL-17F) gene and rheumatoid arthritis (RA) in a Pakistani population. The researchers used bioinformatics tools to analyze the effect of these variants on the IL-17F gene structure and function and evaluate their association with RA. The genetic variants were predicted to cause disease phenotypes and increase the susceptibility to RA. The study found a strong positive association between the genetic variant rs763780 and the risk of developing RA at both the genotypic and allelic levels. The genotypic association was statistically significant (χ2 = 111.8; P value <0.0001), as was the allelic level (P value 0.0008). These findings suggest that the presence of this genetic variant may increase the susceptibility to RA.

Featured Image

Why is it important?

The study is important because it sheds light on the role of genetic factors in the development of rheumatoid arthritis (RA) by examining the association between genetic variants of the IL-17F gene and the risk of developing RA in Pakistani patients. Understanding the relationship between genetics and disease susceptibility can help in the development of more personalized treatment strategies and improve our overall understanding of the underlying mechanisms of RA. Key Takeaways: 1. The IL-17F gene plays a crucial role in RA by promoting inflammation and angiogenesis. 2. Three exonic SNPs (rs2397084, rs11465553, and rs763780) were analyzed for their effect on the structure and function of the IL-17F gene and their association with RA in Pakistani patients. 3. The genetic variant rs763780 was found to be significantly associated with an increased risk of developing RA at both the genotypic and allelic levels. 4. The genetic variant rs11465553 also showed a significant distribution among RA cases, but it did not reach statistical significance. 5. The study utilized multiple in-silico tools to assess the deleterious impacts of the variants on the structure and function of the IL-17F protein, predicting that these variants may structurally and functionally affect the protein. 6. The study highlights the importance of genetic factors in the development of RA and the potential of IL-17F as a therapeutic target.